Eugia Pharma Specialities Ltd receives USFDA final approval Lenalidomide Capsules

Eugia Pharma Specialities Ltd, subsidiary of Aurobindo Pharma Ltd has received a final approval from the USFDA to manufacture and market Lenalidomide Capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg

Related Keywords

,Eugia Pharma Specialities ,Eugia Pharma Specialities Ltd ,Us Food Drug Administration ,Aurobindo Pharma ,Bristol Myers Squibb Company ,Eugia Pharma Speciality Group ,Pharma Limited ,Eugia Pharma Specialities Limited ,Drug Administration ,Lenalidomide Capsules ,Reference Listed Drug ,Revlimid Capsules ,Bristol Myers Squibb ,Aurobindo Pharma Limited ,Aurobindopharma ,Ine406a01037 ,Pharmaceuticals ,Finalapproval ,Usfda ,Lenalidomidecapsules ,